Chemocentryx (CCXI) Holder Bvf Trimmed Holding by $862,370; Hrt Financial Decreased Its Cisco Sys (CSCO) Stake by $307,278 – The Financial Examiner

ChemoCentryx, Inc. (NASDAQ:CCXI) Logo

Bvf Inc decreased its stake in Chemocentryx Inc (CCXI) by 1.27% based on its latest 2018Q4 regulatory filing with the SEC. Bvf Inc sold 86,237 shares as the company’s stock rose 6.99% with the market. The hedge fund held 6.69 million shares of the health care company at the end of 2018Q4, valued at $72.96 million, down from 6.77M at the end of the previous reported quarter. Bvf Inc who had been investing in Chemocentryx Inc for a number of months, seems to be less bullish one the $740.18 million market cap company. The stock increased 4.30% or $0.58 during the last trading session, reaching $14.08. About 468,131 shares traded. ChemoCentryx, Inc. (NASDAQ:CCXI) has risen 12.22% since April 3, 2018 and is uptrending. It has outperformed by 7.85% the S&P500. Some Historical CCXI News: 09/03/2018 – ChemoCentryx 4Q Rev $56.3M; 10/05/2018 – Invus Public Equities Advisors Exits Position in ChemoCentryx; 22/03/2018 – ChemoCentryx Publishes Novel Findings of Role of CCR2 in Kidney Glomerulus, Supporting Advancement of CCR2 Inhibitor CCX140 in the Treatment of Focal Segmental Glomerulosclerosis (FSGS); 09/03/2018 – ChemoCentryx Expects to Utilize Between $65M-$75M Cash and Investments in FY18; 09/03/2018 – CCXI PLANS TO START DEVT AVACOPAN IN HIDRADENITIS SUPPURATIVA; 11/04/2018 – ChemoCentryx Announces Presentation During National Kidney Foundation 2018 Spring Clinical Meeting; 09/03/2018 ChemoCentryx 4Q EPS 80c; 09/03/2018 – ChemoCentryx 4Q Net $39.7M; 22/03/2018 – ChemoCentryx Publishes Novel Findings of Role of CCR2 in Kidney Glomerulus, Supporting Advancement of CCR2 Inhibitor CCX140 in; 09/05/2018 – CHEMOCENTRYX INC – QTRLY DILUTED NET LOSS PER COMMON SHARE $0.19

Hrt Financial Llc decreased its stake in Cisco Sys Inc (CSCO) by 48.25% based on its latest 2018Q4 regulatory filing with the SEC. Hrt Financial Llc sold 7,146 shares as the company’s stock rose 8.18% with the market. The institutional investor held 7,663 shares of the technology company at the end of 2018Q4, valued at $332,000, down from 14,809 at the end of the previous reported quarter. Hrt Financial Llc who had been investing in Cisco Sys Inc for a number of months, seems to be less bullish one the $243.39 billion market cap company. The stock increased 0.56% or $0.31 during the last trading session, reaching $55.29. About 17.26 million shares traded. Cisco Systems, Inc. (NASDAQ:CSCO) has risen 16.80% since April 3, 2018 and is uptrending. It has outperformed by 12.43% the S&P500. Some Historical CSCO News: 16/05/2018 – Cisco Systems: Initiated Restructuring in 3Q to Realign Organization and Enable Investmet in Key Areas; 29/03/2018 – SiriusDecisions Recognizes Cisco, Huron Consulting Group, Illumina, Imprivata and Vocera as Winners of the 2018 Return on; 04/04/2018 – Cloudian to Demonstrate IP-Based Media Workflows with Cisco at NAB Show 2018; 22/05/2018 – Lumos Data Centers Launches Suite of laaS Solutions; 16/05/2018 – Cisco Systems 3Q Cash, Equivalents, Investments $54.4B; 17/05/2018 – Tech Down After Cisco Outlook — Tech Roundup; 16/05/2018 – Cisco Systems 3Q Adj EPS 66c; 19/04/2018 – Cisco ACI Is Data Center Solution of Choice for Service Providers Worldwide; 10/05/2018 – FORMER CISCO CEO JOHN CHAMBERS JOINS BLOOM ENERGY BOARD; 18/05/2018 – Tech Down as Tesla, Cisco Remain Weak — Tech Roundup

Investors sentiment decreased to 0.93 in 2018 Q4. Its down 0.05, from 0.98 in 2018Q3. It fall, as 7 investors sold CCXI shares while 38 reduced holdings. 18 funds opened positions while 24 raised stakes. 27.13 million shares or 1.23% more from 26.80 million shares in 2018Q3 were reported. Franklin owns 1.38 million shares for 0.01% of their portfolio. Rhumbline Advisers has invested 0% in ChemoCentryx, Inc. (NASDAQ:CCXI). The New York-based Metropolitan Life Ins Com Ny has invested 0% in ChemoCentryx, Inc. (NASDAQ:CCXI). Bb&T Securities Llc holds 114,827 shares. Invesco Ltd holds 0% in ChemoCentryx, Inc. (NASDAQ:CCXI) or 143,834 shares. Credit Suisse Ag stated it has 0% in ChemoCentryx, Inc. (NASDAQ:CCXI). Wasatch Advsr has invested 0.34% in ChemoCentryx, Inc. (NASDAQ:CCXI). Zebra Capital Management Ltd holds 0.1% or 14,396 shares. Vanguard Group holds 1.36 million shares. D E Shaw And holds 0% or 214,899 shares. Her Majesty The Queen In Right Of The Province Of Alberta As Represented By Alberta Inv owns 37,000 shares. Barclays Public Ltd owns 0% invested in ChemoCentryx, Inc. (NASDAQ:CCXI) for 5,866 shares. 13,165 are owned by One Trading Ltd Partnership. Trexquant Limited Partnership has 33,717 shares for 0.02% of their portfolio. Moreover, Paw Corporation has 0.68% invested in ChemoCentryx, Inc. (NASDAQ:CCXI) for 50,000 shares.

Bvf Inc, which manages about $999.89M and $765.19 million US Long portfolio, upped its stake in Xenon Pharmaceuticals Inc by 623,221 shares to 1.79M shares, valued at $11.29 million in 2018Q4, according to the filing. It also increased its holding in Arqule Inc (NASDAQ:ARQL) by 402,516 shares in the quarter, for a total of 6.23 million shares, and has risen its stake in Calithera Biosciences Inc (NASDAQ:CALA).

Since October 16, 2018, it had 0 buys, and 8 sales for $87.64 million activity. KANAYA SUSAN M sold 37,893 shares worth $457,747. Another trade for 7.34M shares valued at $85.85M was sold by GLAXOSMITHKLINE PLC. On Thursday, January 10 the insider Schall Thomas J. sold $447,092.

More notable recent ChemoCentryx, Inc. (NASDAQ:CCXI) news were published by: Benzinga.com which released: “60 Stocks Moving In Wednesday’s Mid-Day Session – Benzinga” on March 27, 2019, also Benzinga.com with their article: “10 Biggest Price Target Changes For Wednesday – Benzinga” published on March 27, 2019, Nasdaq.com published: “ChemoCentryx (CCXI) Reports Q4 Loss, Lags Revenue Estimates – Nasdaq” on March 11, 2019. More interesting news about ChemoCentryx, Inc. (NASDAQ:CCXI) were released by: Nasdaq.com and their article: “ChemoCentryx (CCXI) Looks Good: Stock Adds 5.5% in Session – Nasdaq” published on March 19, 2019 as well as Globenewswire.com‘s news article titled: “ChemoCentryx Appoints Rita Jain, M.D. to Board of Directors – GlobeNewswire” with publication date: March 28, 2019.

Investors sentiment increased to 0.91 in 2018 Q4. Its up 0.06, from 0.85 in 2018Q3. It improved, as 68 investors sold CSCO shares while 701 reduced holdings. 140 funds opened positions while 557 raised stakes. 3.17 billion shares or 0.63% more from 3.15 billion shares in 2018Q3 were reported. Botty Ltd Liability Company owns 25,620 shares for 0.39% of their portfolio. Harvey Capital Mngmt Inc accumulated 0.18% or 7,625 shares. Essex Finance Services holds 1.11% of its portfolio in Cisco Systems, Inc. (NASDAQ:CSCO) for 83,537 shares. Cap City Trust Fl has invested 0.32% of its portfolio in Cisco Systems, Inc. (NASDAQ:CSCO). Cs Mckee Lp owns 630,240 shares. First Interstate Bank holds 2.24% or 208,706 shares in its portfolio. Adams Asset Advisors Lc holds 0.85% of its portfolio in Cisco Systems, Inc. (NASDAQ:CSCO) for 138,469 shares. Kentucky Retirement Insurance Fund reported 88,933 shares. Greystone Managed Invs reported 65,614 shares. Kings Point Mngmt has 152,212 shares. Partnervest Advisory Ser Llc has 22,381 shares. Lee Danner & Bass has invested 0.7% of its portfolio in Cisco Systems, Inc. (NASDAQ:CSCO). Ballentine Ptnrs Llc holds 0.13% of its portfolio in Cisco Systems, Inc. (NASDAQ:CSCO) for 51,267 shares. Somerset Tru invested in 120,343 shares or 3.03% of the stock. Mason Street Advisors Ltd Liability owns 633,865 shares or 0.68% of their US portfolio.

Hrt Financial Llc, which manages about $699.70M US Long portfolio, upped its stake in Rh by 7,264 shares to 11,947 shares, valued at $1.43 million in 2018Q4, according to the filing. It also increased its holding in Hewlett Packard Enterprise C by 99,390 shares in the quarter, for a total of 112,337 shares, and has risen its stake in M & T Bk Corp (NYSE:MTB).

Since November 23, 2018, it had 0 insider buys, and 6 sales for $7.80 million activity. On Monday, December 3 Tan Irving sold $1.36M worth of Cisco Systems, Inc. (NASDAQ:CSCO) or 28,000 shares. Shares for $196,324 were sold by CHANDLER MARK D. Shares for $3.32M were sold by Kramer Kelly A. on Thursday, November 29. $1.52 million worth of Cisco Systems, Inc. (NASDAQ:CSCO) was sold by BHATT PRAT. WEST STEVEN M sold $1.20 million worth of stock.

More notable recent Cisco Systems, Inc. (NASDAQ:CSCO) news were published by: Nasdaq.com which released: “Cisco Systems (CSCO) Outpaces Stock Market Gains: What You Should Know – Nasdaq” on March 21, 2019, also Benzinga.com with their article: “Jim Cramer Advises His Viewers On Cisco, Nokia, Splunk And More – Benzinga” published on March 21, 2019, Nasdaq.com published: “The Zacks Analyst Blog Highlights: Boeing, Starbucks, Procter & Gamble, Cisco and Philip Morris – Nasdaq” on March 06, 2019. More interesting news about Cisco Systems, Inc. (NASDAQ:CSCO) were released by: Nasdaq.com and their article: “Technology Sector Update for 03/22/2019: NOK, OSS, JKS, ZUO, MSFT, AAPL, IBM, CSCO, GOOG – Nasdaq” published on March 22, 2019 as well as Nasdaq.com‘s news article titled: “Better IoT Buy: Sierra Wireless vs. Cisco – Nasdaq” with publication date: March 14, 2019.

Cisco Systems, Inc. (NASDAQ:CSCO) Institutional Positions Chart


Receive News & Ratings Via Email – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings with our FREE daily email newsletter.



Source link

0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply

Your email address will not be published. Required fields are marked *